shortagewatch

Home / Famotidine / Japan

ATC A02BA03 · updated 2 Nov 2026

Famotidine shortage in Japan

Is there a Famotidine shortage in Japan?

Yes. As of 2 Nov 2026, 14 Famotidine products are reported short in Japan, the first since 8 Sep 2025. No return date has been given. Main reason: increased demand.

Also short in Canada, Ireland, Czechia. All countries.

Affected products in Japan

CountryProductCompanySinceExpected backReason
ファモチジン注射用10mg「テバ」T’sファーマ8 Sep 2025not givenQuality problem or recall
Quality problem
ファモチジン注射用20mg「テバ」T’sファーマ1 Dec 2025not givenQuality problem or recall
Quality problem
ファモチジン静注20mg「日新」 limitedNissin Pharmaceutical9 Oct 2026not givenManufacturing problem
ファモチジン錠10mg「TCK」Tatsumi Kagaku15 Oct 2026not givenOther
ファモチジン静注液10mg「サワイ」 limitedSawai20 Oct 2026not givenManufacturing problem
ファモチジン静注液20mg「サワイ」 limitedSawai20 Oct 2026not givenManufacturing problem
ファモチジン静注液10mg「日医工」 limitedNichi-Iko21 Oct 2026not givenIncreased demand
ファモチジン静注液20mg「日医工」 limitedNichi-Iko21 Oct 2026not givenIncreased demand
ガスター注射液10mg limitedLTLファーマ23 Oct 2026not givenIncreased demand
ガスター注射液20mg limitedLTLファーマ23 Oct 2026not givenIncreased demand
ファモチジン静注10mg「杏林」 limitedキョーリンリメディオ26 Oct 2026not givenIncreased demand
ファモチジン静注20mg「杏林」 limitedキョーリンリメディオ26 Oct 2026not givenIncreased demand
ファモチジン注射液10mg「トーワ」 limitedTowa (Pensa)29 Oct 2026not givenIncreased demand
ファモチジン注射液20mg「トーワ」 limitedTowa (Pensa)29 Oct 2026not givenIncreased demand

Source

MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.